Lessons from immuno-oncology: a new era for cancer nanomedicine?

被引：33

作者：

Jiang, Wen ^{[1
]}

Yuan, Hengfeng ^{[2
,3
]}

Chan, Charles K. ^{[4
]}

von Roemeling, Christina A. ^{[3
]}

Yan, Zuoqin ^{[2
]}

Weissman, Irving L. ^{[4
,5
,6
]}

Kim, Betty Y. S. ^{[3
,7
,8
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[2] Fudan Univ, Zhongshan Hosp, Dept Orthoped, 111 Yixueyuan Rd, Shanghai, Peoples R China

[3] Mayo Clin, Coll Med, Dept Neurosurg, 4500 San Pablo Rd, Jacksonville, FL 32224 USA

[4] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, 450 Serra Mall, Palo Alto, CA 94305 USA

[5] Stanford Univ, Dept Pathol, 450 Serra Mall, Palo Alto, CA 94305 USA

[6] Stanford Univ, Dept Dev Biol, 450 Serra Mall, Palo Alto, CA 94305 USA

[7] Mayo Clin, Coll Med, Dept Canc Biol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA

[8] Mayo Clin, Coll Med, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2017年 / 16卷 / 06期

关键词：

DELIVERY;

D O I：

10.1038/nrd.2017.34

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Despite a decade of intensive preclinical research, the translation of cancer nanomedicine to the clinic has been slow. Here, we discuss how recent lessons learned from the successes with immuno-oncology therapies could be applied to cancer nanomedicine and how this may help to overcome some of the key technical challenges in this field.

引用

页码：369 / 370

页数：2

共 50 条

[1] Lessons from immuno-oncology: a new era for cancer nanomedicine?
Wen Jiang
Hengfeng Yuan
Charles K. Chan
Christina A. von Roemeling
Zuoqin Yan
Irving L. Weissman
Betty Y. S. Kim
[J]. Nature Reviews Drug Discovery, 2017, 16 : 369 - 370
[2] Cancer Nanomedicine: Lessons for Immuno-Oncology
Sengupta, Shiladitya
[J]. TRENDS IN CANCER, 2017, 3 (08): : 551 - 560
[3] Designing nanomedicine for immuno-oncology
Wen Jiang
Christina A. von Roemeling
Yuanxin Chen
Yaqing Qie
Xiujie Liu
Jianzhu Chen
Betty Y. S. Kim
[J]. Nature Biomedical Engineering, 1
[4] Designing nanomedicine for immuno-oncology
Jiang, Wen
von Roemeling, Christina A.
Chen, Yuanxin
Qie, Yaqing
Liu, Xiujie
Chen, Jianzhu
Kim, Betty Y. S.
[J]. NATURE BIOMEDICAL ENGINEERING, 2017, 1 (02):
[5] Cancer Immunoediting in the Era of Immuno-oncology
Gubin, Matthew M.
Vesely, Matthew D.
[J]. CLINICAL CANCER RESEARCH, 2022, 28 (18) : 3917 - 3928
[6] The immuno-oncology framework Enabling a new era of cancer therapy
Hoos, Axel
Britten, Cedrik M.
[J]. ONCOIMMUNOLOGY, 2012, 1 (03): : 334 - 339
[7] Nanomedicine and macroscale materials in immuno-oncology
Sun, Qingxue
Barz, Matthias
De Geest, Bruno G.
Diken, Mustafa
Hennink, Wim E.
Kiessling, Fabian
Lammers, Twan
Shi, Yang
[J]. CHEMICAL SOCIETY REVIEWS, 2019, 48 (01) : 351 - 381
[8] Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
Hegde, Samarth
[J]. INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (SUPPL 1) : 118 - 127
[9] Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
Samarth Hegde
[J]. Indian Journal of Surgical Oncology, 2021, 12 : 118 - 127
[10] From New directions in immuno-oncology
Diana Romero
[J]. Nature Reviews Clinical Oncology, 2019, 16 : 660 - 660

← 1 2 3 4 5 →